Investigators screened 226 community-dwelling adults aged 60 years and older across Seberang Perai Utara (SPU), an urban mainland district of Penang. They identified sarcopenia in 32.7% of participants. The cohort included 15.0% classified with severe sarcopenia and 17.7% meeting criteria for sarcopenia under the chosen diagnostic framework. These proportions emerged from a district-level outreach effort spanning six primary-care clinic sites and community open days conducted during September 2025.
This observed prevalence sits within previously reported national ranges but fills a local data gap: prior Malaysian studies reported variable regional prevalence, and no published estimate existed for Penang before this work. The study therefore provides the first local estimate for SPU using consistent measurement protocols and AWGS criteria current at the time of data collection.
The research team applied the AWGS 2019 consensus for case identification, requiring assessment of muscle quantity, muscle strength, and physical performance. Muscle mass estimation relied on bioelectrical impedance analysis (BIA) using an Inbody 270 device. The investigators followed manufacturer and clinical research protocols for BIA and adopted AWGS 2019 cutoffs for appendicular skeletal muscle mass index (ASM index: <7.0 kg/m² for males, <5.7 kg/m² for females).
Muscle strength was measured by handgrip dynamometry. Physical performance was evaluated with the five-times chair stand test. Height and weight were measured using standardized equipment and procedures; BMI was calculated from those measurements. Physical activity was captured with the International Physical Activity Questionnaire (IPAQ) – Short Form and converted to MET-minutes/week to classify participants as inactive, minimally active, or health-enhancing physically active (HEPA active).
Because data collection closed before the release of the AWGS 2025 update, the study team explicitly used AWGS 2019 definitions. The source did not report additional device calibration details beyond standard manufacturer protocols or specific handgrip thresholds used in analyses beyond AWGS 2019 guidance.
The study used multivariable logistic regression to examine correlates of sarcopenia. Two factors were statistically significant in the adjusted model. Higher BMI was associated with lower odds of sarcopenia (adjusted OR 0.794; 95% CI 0.723–0.873; p < 0.001). The investigators interpreted this as consistent with prior observations that lower body mass is linked to higher sarcopenia risk in older adults.
Physical activity level demonstrated a significant association with sarcopenia overall (p = 0.013). Compared with HEPA active participants, those classified as minimally active had markedly higher odds of sarcopenia (adjusted OR 4.393; 95% CI 1.583–12.193; p = 0.004). The source did not report adjusted ORs for the inactive group versus HEPA active in the final model, nor did it provide stratified MET-min/week distributions in the summary text.
These cross-sectional associations indicate that, within this SPU sample, both lower BMI and lower physical activity are correlated with higher probability of meeting AWGS 2019 sarcopenia criteria. The analysis controlled for candidate predictors entered into the model; the source reported seven predictor parameters in the final multivariable model and confirmed sufficient events per variable for the achieved number of sarcopenic cases.
Sampling combined clinic-based recruitment during routine visits and targeted community outreach across six health clinics in SPU: Klinik Kesihatan Sungai Dua, Mak Mandin, Butterworth, Kepala Batas, Penaga, and Tasek Gelugor. The study population included residents of SPU who had lived in the district for more than one year and were free of acute conditions that would preclude physical performance testing. Exclusion criteria included severe cognitive impairment, advanced physical disability, active neurological deficits, end-stage organ dysfunction, acute infection, or acute musculoskeletal injury.
The sample size target of 226 was pre-specified based on power calculations to detect an association between age and sarcopenia; the team accounted for expected non-response and confirmed that the number of sarcopenic cases met events-per-variable recommendations for multivariable logistic regression.
Strengths include standardized, on-site phenotyping with BIA, handgrip, and chair-stand testing and adherence to AWGS 2019 criteria at the time of data collection. The study addressed a previously empty regional evidence gap for Penang and used a pre-specified sample-size calculation.
Limitations stem from the cross-sectional design and convenience-based recruitment. These choices limit causal inference and may affect representativeness for the broader SPU older-adult population. The source did not report detailed selection-response rates or full distributions for some covariates in the summary text. The study also used AWGS 2019 definitions because data collection preceded AWGS 2025; how prevalence would compare under the updated consensus was not reported.
Unanswered clinical questions documented by the authors include whether longitudinal declines in activity or weight predict incident sarcopenia in this population, how intervention on physical activity would modify risk, and how AWGS 2025 criteria would alter case classification in this cohort. These issues remain to be resolved in future prospective work or reanalysis under updated diagnostic thresholds.